Injectable Gelled Multiple Emulsion for Glucose‐Responsive Insulin Delivery

Kofi Oti Boakye‐Yiadom,Qijing Chen,Yilong Teng,Chenshuang Zhang,Bin Hu,Xue‐Qing Zhang
DOI: https://doi.org/10.1002/adhm.202304195
IF: 10
2024-07-14
Advanced Healthcare Materials
Abstract:The figure illustrates the formation of a glucose‐responsive drug delivery formulation in the treatment of T1D in a streptozotocin (STZ)‐induced diabetes mouse model. A single dose of the gelled emulsion‐based insulin delivery system in vivo maintains normoglycemic state in diabetic mice for a longer duration. A glucose‐responsive insulin delivery system that sustains blood glucose equilibrium for an extended duration can address the low therapeutic window of insulin in diabetes treatment. Herein, insulin is loaded in a water‐in‐oil‐in‐water (W1/O/W2) gelled multiple emulsion using poly (4‐vinylphenylboronic acid) (PVPBA) homopolymer as an effective emulsifier. The gelled multiple emulsion exhibits a high encapsulation efficiency (99%), enhanced stability and remarkable shear‐thinning behavior, making it easy to inject. Under hyperglycemic conditions, the gelled emulsion system instantly binds to glucose molecules and reduces the hydrogen bonds of the PVPBA homopolymer, resulting in insulin release. In a streptozotocin‐induced type 1 diabetic mouse model, a single subcutaneous injection of the gelled emulsion rapidly responds to high blood glucose concentration (BGC) and release insulin in a glucose dependent manner, thus prolonging the antihyperglycemic effect compared with free insulin.
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?